JESSICA PALMIERO: Open Payments
NPI 1568124923 · CICERO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,480 in 82 payments from 17 companies in 2025. Trend: 2023 $1,000 · 2024 $1,019 · 2025 $1,480
Food & beverage: $1,480
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $206 |
| PFIZER INC. | 13 | $194 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $168 |
| Novo Nordisk Inc | 11 | $163 |
| AstraZeneca Pharmaceuticals LP | 8 | $149 |
| Lilly USA, LLC | 6 | $128 |
| Axsome Therapeutics, Inc. | 5 | $85 |
| GlaxoSmithKline, LLC. | 4 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $55 |
Products named: CAPLYTA, AIRSUPRA, VRAYLAR, JARDIANCE, PREVNAR 20, Auvelity, TRELEGY ELLIPTA, MOUNJARO.
Industry payments across NY — which companies pay providers there.
